Pharma

Laurus Labs Ltd

LAURUSLABS · NSE · INE947Q01028
₹1,946.1+0.66%consolidatedstandalone
Thursday, 10 Sept 202610:46 am
Sentiment84 · Extreme Greed
Extreme FearFearNeutralGreedExtreme Greed
Market Cap—
P/E—
P/B—
EPS—
Div Yield—
ROE18.2%
ROCE17.2%
ROE18.2%
1Y Return+83.89%
Avg. Volume2.9M

Price Chart

1,9461,6681,3891,1118321.5Cr3.1CrSept 2025Oct 2025Nov 2025Jan 2026Feb 2026Mar 2026May 2026Jul 2026Sept 2026

52-Week Range

₹823.1₹1,946.1₹1,955
52W Low52W High

About

Laurus Labs Ltd is a Pharma company listed on NSE.

Pharma

Technicals

Free account

Technicals

Create a free account to view momentum, moving averages, and delivery signals.

Register free

Quant

Premium

Quant metrics

Upgrade to view volatility, drawdown, factor, and risk metrics.

Upgrade

Key Ratios

Market Cap—
Current Price₹1,946.1
52W High / Low₹1,955 / ₹823.1
Stock P/E—
Price to Book—
EPS (TTM)—
Dividend Yield—
ROE18.2%
1Y Return+83.89%
Day Change+0.66%

Profit & Loss

ConsolidatedStandalone
Profit and loss statement
PeriodTTMFY26FY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15
Sales₹7,270 Cr₹6,813 Cr₹5,554 Cr
Expenses₹5,236 Cr₹5,028 Cr₹4,499 Cr
Operating Profit₹2,034 Cr₹1,785 Cr₹1,055 Cr
OPM %28.0%26.0%19.0%
Other Income₹54 Cr₹47 Cr₹75 Cr
Depreciation₹487 Cr₹480 Cr₹430 Cr
Interest₹161 Cr₹171 Cr₹216 Cr
Profit Before Tax₹1,439 Cr₹1,182 Cr₹484 Cr
Tax₹348 Cr₹292 Cr₹126 Cr
Net Profit₹1,091 Cr₹890 Cr₹358 Cr
EPS (₹)20.216.56.6
Dividend Payout %—12%18%
Financial history locked

Register free to see 10 more years.

Register free

Quarterly Results

Quarterly results
QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023
Sales₹2,026 Cr₹1,812 Cr₹1,778 Cr₹1,653 Cr
Expenses₹1,388 Cr₹1,299 Cr₹1,298 Cr₹1,250 Cr
Operating Profit₹638 Cr₹512 Cr₹480 Cr₹403 Cr
OPM %32.0%28.0%27.0%24.0%
Depreciation₹124 Cr₹122 Cr₹121 Cr₹120 Cr
Interest₹42 Cr₹40 Cr₹39 Cr₹40 Cr
Net Profit₹362 Cr₹282 Cr₹252 Cr₹194 Cr
EPS (₹)6.85.24.73.6
Quarterly history locked

Register free to see 9 more quarters.

Register free

Balance Sheet

Balance sheet
PeriodFY26FY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15
Liabilities
Equity Capital₹108 Cr₹108 Cr₹108 Cr
Reserves₹5,192 Cr₹4,365 Cr₹4,003 Cr
Borrowings₹2,518 Cr₹2,764 Cr₹2,577 Cr
Other Liabilities₹2,693 Cr₹2,099 Cr₹1,699 Cr
Total Liabilities₹10,511 Cr₹9,336 Cr₹8,387 Cr
Assets
Fixed Assets₹4,371 Cr₹4,123 Cr₹3,890 Cr
Investments₹309 Cr₹233 Cr₹124 Cr
Receivables———
Inventory———
Cash & Equivalents———
Other Assets₹5,058 Cr₹4,521 Cr₹3,950 Cr
Total Assets₹10,511 Cr₹9,336 Cr₹8,387 Cr
Balance sheet history locked

Register free to see 10 more years.

Register free

Cash Flow

Cash flow statement
PeriodOperatingInvestingFinancingNet Cash Flow
FY26₹1,624 Cr₹-1,086 Cr₹-525 Cr₹13 Cr
FY25₹602 Cr₹-680 Cr₹39 Cr₹-39 Cr
FY24₹666 Cr₹-822 Cr₹250 Cr₹93 Cr
FY23
FY22
FY21
FY20
FY19
FY18
FY17
FY16
FY15
Cash flow history locked

Register free to see 10 more years.

Register free

Peer Comparison

Peer comparison
CompanyM.CapP/EROE1Y Return
Sun Pharmaceutical Industries Ltd——+14.78%+7.18%
Dr Reddys Laboratories Ltd——+8.84%-3.74%
Cipla Ltd——+11.77%-5.50%
Apollo Hospitals Enterprise Ltd——+22.64%+23.01%
Divis Laboratories Ltd₹2,50,065 Cr83.9+16.5%+46.29%

Mutual Fund Holdings

Free account

Mutual fund holdings

Create a free account to see institutional ownership snapshots.

Register free

Bulk & Block Deals

Free account

Bulk & block deals

Create a free account to view recent institutional deal activity.

Register free

Analyst Estimates

Free account

Analyst estimates

Create a free account to view analyst estimate summaries.

Register free

Latest News

2026-09-10Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationBSE Filing2026-07-24Laurus Labs Ltd (BOM:540222) Q1 2027 Earnings Call Highlights: Robust Revenue Growth and ...GuruFocus.com

Documents & Filings

rupiya.io is for research and education only. Metrics shown are not investment advice. Validate with SEBI-regulated disclosures before acting.